Diagnostic imaging  

Catholic University in Rome receives CT laser mammography system to support clinical research

20 December 2004

Imaging Diagnostic Systems, Inc. (BULLETIN BOARD: IMDS) announced today that the Catholic University in Rome, Italy has signed a clinical collaboration agreement and that a CT Laser Mammography (CTLM(R)) system has been shipped to their Department of Radiology.

"We are delighted to have Professor Bonomo and the Department of Radiology of the Catholic University in Rome join our clinical development efforts. This agreement marks our sixth of eight targeted European sites. These relationship will strengthen our European presence and should help IDSI specifically address the needs of regional Clinicians and patients," stated Deborah O'Brien, Senior Vice President.

"I am deeply interested in the potential of optical imaging of the breast (Computed Tomography Laser Mammography) for improving the diagnosis and treatment of breast cancer. We have already received a grant from the Korten Foundation to pursue research comparing this new breakthrough technology with X-ray mammography, magnetic resonance imaging and ultrasound using echocontrast. We plan to make the CTLM installation at my University in Rome a demonstration center in optical imaging for the whole of Italy," stated Lorenzo Bonomo, professor and Chairman of the Department of Radiological Sciences of Catholic University in Rome.

The CTLM(R) system is the first patented breast imaging system that utilizes state-of the-art laser technology and patented algorithms to create 3-D cross-sectional images of the breast. It is a non-invasive, painless examination that does not expose the patient to radiation or require breast compression. Imaging Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian License, UL listing, ISO 9001:2000-13488 certification, China SFDA and FDA export certification for its CT Laser Breast Imaging system. The Company is seeking Pre-Market Approval (PMA) from the Food and Drug Administration (FDA) for its CTLM(R) system to be used as an adjunct to mammography.

For more information please visit website at: www.imds.com/


To top